Stay updated with breaking news from Kiersten Stead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Climate-change warriors heed this call! If you want to demo your climate tech at TC Sessions: Climate 2022 on June 14 at UC Berkeley, time is running out. We have only two — count ‘em two — Startup Demo Packages left, and your last day to purchase one is May 14. It’s Now O’clock: Buy […]
From the minds behind TechCrunch comes a brand-new TC Sessions event dedicated to the climate crisis. Leading scientists, entrepreneurs, VCs and more will gather on June 14 at UC Berkeley to examine the role of tech and startups in mitigating and adapting to the existential threat you know and dread. I know this reporter will […]
/PRNewswire/ -- Creyon Bio, Inc. ("Creyon Bio"), a drug development company engineering RNA-based medicines and their components (oligonucleotide-based...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stemson Therapeutics Raises $15M in Series A Funding Stemson Therapeutics, a San Diego, CA-based pre-clinical stage cell therapy company, closed a $15m Series A financing. The round was led by DCVC Bio with participation from Genoa Ventures, AbbVie Ventures and other investors. In addition, Kiersten Stead, Ph.D., Co-Managing Partner at DCVC Bio and Jenny Rooke, Ph.D., Managing Director at Genoa Ventures will join Stemson’s Executive Chairman Matt Posard and Chief Executive Officer and co-founder Geoff Hamilton on the board of directors. The company intends to use the funds to adva...